The use of antidepressant drugs in dermatology

Journal of the European Academy of Dermatology and Venereology

Volumn 15, Issue 6, 2001, Pages 512-518

  Gupta, M A ^a,c   Gupta, A K ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

Pharmacology; Psychiatric disorder; Psychodermatology; Selective serotonin reuptake inhibitors (SSRI); Treatment

Indexed keywords

AMFEBUTAMONE; AMINE OXIDASE (FLAVIN CONTAINING); AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ASTEMIZOLE; CITALOPRAM; CLOMIPRAMINE; CODEINE; CYTOCHROME P450 2D6; CYTOCHROME P450 3A; CYTOCHROME P450 ISOENZYME; DOXEPIN; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; HISTAMINE H1 RECEPTOR; IMIPRAMINE; KETOCONAZOLE; NEFAZODONE; NEUROLEPTIC AGENT; PAROXETINE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TERFENADINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

ACNE; BODY DYSMORPHIC DISORDER; BODY IMAGE; CARDIOTOXICITY; CHILD ABUSE; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; DERMATITIS; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG INHIBITION; DRUG METABOLISM; HUMAN; OBSESSION; POSTTRAUMATIC STRESS DISORDER; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; PSORIASIS; RECEPTOR BLOCKING; REVIEW; SKIN DISEASE; SOCIAL PHOBIA; TRICHOTILLOMANIA; URTICARIA;

EID: 0035676579     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2001.00278.x     Document Type: Review

References (45)

1. Psychiatric morbidity in dermatological outpatients: An issue to be recognized
2. The use of psychotropic drugs in dermatology
3. Antidepressant drugs in dermatology
4. Psychodermatology: An update
5. Dermatopsychosomatics: Classification, physiology, and therapeutic approaches
6. Depression and suicidal ideation in dermatology patients: A comparison of patients with acne, alopecia areata, atopic dermatitis and psoriasis
7. A psychocutaneous profile of psoriasis patients who are stress reactors: A study of 127 patients
8. An overview of atopic dermatitis: Toward a bio-behavioral integration
9. The relation of stress and family environment to atopic dermatitis symptoms in children
10. Antidepressant drugs in dermatology
11. Amitriptyline versus placebo in post-herpetic neuralgia
12. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy
13. Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria
14. Doxepin in the treatment of chronic urticaria
15. Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in the treatment of idiopathic cold urticaria
16. Evaluation and treatment of 'psychogenic' pruritus and self-excoriation
17. Effects of trimeprazine and trimipramine on nocturnal scratching in patients with atopic eczema
18. The doxepin study group: Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream
19. Antimuscarinic and other receptor-blocking properties of antidepressants
20. Imipramine in alopecia areata: A double-blind, placebo-controlled study
21. Fluoxetine is an effective treatment for neurotic excoriations: A case report
22. Severe recurrent urticaria associated with panic disorder: A syndrome responsive to selective serotonin reuptake inhibitor (SSRI) antidepressants?
23. Cytochrome P-450 3A: Interactions with dermatological therapies
24. Metabolism of drugs by cytochrome P450 3A isoforms: Implications for drug interactions in psychopharmacology
25. Antidepressant drug interactions and the cytochrome P450 system
26. Depression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria
27. Suicidal ideation in psoriasis
28. Body dysmorphic disorder: Clinical features and drug treatment
29. Paroxetine in social phobia/social anxiety disorder. Randomized, double-blind, placebo-controlled study
30. Antidepressant treatment of posttraumatic stress disorder
31. Dermatological non-disease. A common and potentially fatal disturbance of cutaneous body image
32. Non-weight related body image concerns among female eating-disordered patients and nonclinical controls: Some preliminary observations
33. The self-inflicted dermatoses: A critical review
34. Dermatitis artefacta and sexual abuse
35. Dermatitis artefacta in mother and baby as child abuse
36. Dermatological signs in anorexia nervosa and bulimia nervosa
37. Psychosomatic factors affecting self-excoriative behavior among women with mild to moderate facial acne vulgaris
38. Characteristics of 60 adult chronic hair pullers
39. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling)
40. Dissociative symptoms and self-induced dermatoses: A preliminary empirical study